HOME >> MEDICINE >> NEWS
Robert Wood Johnson Medical School researcher receives fellowship for work in Canavan Disease

Scott McPhee, PhD, of Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey in Camden, has been selected to receive the first Canavan Disease Clinical Research Training Fellowship which is co-sponsored by the Canavan Foundation and the American Academy of Neurology Foundation.

The Canavan Disease Clinical Research Training Fellowship supports research toward the cause, treatment or cure of Canavan disease, a rare and fatal genetic disorder affecting the myelin sheath that insulates and protects nerves and the brain. The two-year fellowship will provide McPhee with $50,000 each year, plus a stipend for tuition reimbursement.

The Canavan Foundation's mission is to help prevent Canavan disease through education and testing and to support research efforts, which have yet to find an effective therapy. Children with Canavan disease cannot crawl or walk, may suffer from seizures or mental retardation, and cannot perform activities of daily living. Canavan disease generally results in death by 10 years of age. For more information about the Canavan Foundation, visit www.canavanfoundation.org.

McPhee plans to examine the development and genetic regulation of myelinating cells called oligodendrocytes, which form the white matter in the brain.

"I am very grateful that I have been honored with this grant, and I plan to make the very most out of this wonderful opportunity," said McPhee, who works in the Cell & Gene Therapy Center at the Medical School.

"My objectives are to determine the underlying disease mechanism in Canavan disease, and to improve our understanding of how the brain normally develops," said McPhee. "The research project will examine how certain cells in the brain develop in the setting of Canavan disease, compared to the normal fetal or newborn brain."

McPhee will be honored during the American Academy of Neurology 56th Annual M
'"/>

Contact: Marilee Reu
mreu@aan.com
651-695-2789
American Academy of Neurology
4-Mar-2004


Page: 1 2

Related medicine news :

1. GSA bestows Robert W. Kleemeier Award to University of Texas Health Science Centers Smith
2. Rutgers announces Robert Wood Johnson Foundation Investigator Awards in Health Policy Research
3. Federal institutes and the Robert Wood Johnson Foundation create Tobacco Use Research Centers
4. Medically supervised drug injection facilities safer for users
5. Medical molecules designed to respond to visible light that can penetrate tissue
6. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
7. UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU
8. New data on Orqis Medicals Cancion CRS to be reported at ACC
9. Medical technologies may hinder rather than help newborn survival
10. Medical meeting to feature research findings and disease prevention and health promotion sessions
11. LA BioMed Medical/Research briefs January 2005

Post Your Comments:
(Date:4/18/2014)... turns 160 years of neuroanatomy on its head. , ... essential for the fast transmission of impulses along the ... thought, according to a new work lead by Professor ... and the University,s Department of Stem Cell and Regenerative ... Department of Molecular and Cellular Biology. , "Myelin is ...
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
(Date:4/17/2014)... in benign prostate tissue was associated with high-grade, ... found even in those with low prostate-specific antigen ... Cancer Epidemiology, Biomarkers & Prevention , a ... , An analysis of prostate tissue biopsies collected ... the Prostate Cancer Prevention Trial (PCPT) found that ...
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2
(Date:1/15/2014)... is very pleased to announce the appointment of Mr. ... Mark was promoted from his current role of Chief Operating ... in Massachusetts , Mississippi ... 2012 with 20+ years of broad-based operations, sales, engineering and ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
Cached News: